CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-24 | Hyep Ivan Chief Financial Officer | Option exercise 10b5-1 | +17,795 | $3.79 | $67K | 163,150 |
| 2025-11-24 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −17,795 | $18.55 | $330K | 145,355 |
| 2025-11-24 | Hyep Ivan Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,795 | 98,184 | ||
| 2025-11-21 | Hyep Ivan Chief Financial Officer | Option exercise 10b5-1 | +605 | $3.79 | $2K | 145,960 |
| 2025-11-21 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −605 | $18.15 | $11K | 145,355 |
| 2025-11-21 | Hyep Ivan Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −605 | 115,979 | ||
| 2025-11-21 | Cohlhepp Ryan President and COO | Option exercise 10b5-1 | +8,000 | $3.79 | $30K | 206,141 |
| 2025-11-21 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $18.05 | $144K | 198,141 |
| 2025-11-21 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $18.05 | $81K | 193,641 |
| 2025-11-21 | Cohlhepp Ryan President and COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,000 | 149,334 | ||
| 2025-10-16 | Mazumdar Claire Chief Executive Officer | Option exercise 10b5-1 | +24,103 | $3.79 | $91K | 333,995 |
| 2025-10-16 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −24,103 | $18.83 | $454K | 309,892 |
| 2025-10-16 | Mazumdar Claire Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −24,103 | 277,270 | ||
| 2025-10-15 | Cohlhepp Ryan President and COO | Option exercise 10b5-1 | +8,000 | $3.79 | $30K | 210,641 |
| 2025-10-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $18.16 | $145K | 202,641 |
| 2025-10-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $18.16 | $82K | 198,141 |
| 2025-10-15 | Cohlhepp Ryan President and COO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,000 | 157,334 | ||
| 2025-10-15 | Mazumdar Claire Chief Executive Officer | Option exercise 10b5-1 | +13,289 | $3.79 | $50K | 323,181 |
| 2025-10-15 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −13,289 | $18.84 | $250K | 309,892 |
| 2025-10-15 | Mazumdar Claire Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,289 | 301,373 |
Page 9 of 14 · 276 trades